| Zeria's "Two Wheels" Business Model |
 |
|
| Strength from Balanced Operations Based on Two Mainstay Businesses |
|
|
|
A chief feature of Zeria’s operations is its well-balanced business portfolio consisting of Ethical Pharmaceuticals and Consumer Healthcare, centering on OTC products.
In our Ethical Pharmaceuticals business, particularly in gastrointestinal therapies, by offering a variety of products and a lineup covering the upper and lower gastrointestinal tracts, we have earned high acclaim and trust from medical professionals as a “Specialty Pharma.”
In the Consumer Healthcare business, we launched Chondroitin early on as an ethical drug in 1959. Chondroitin ZS Tablets have achieved recognition as a national brand in the field of internal medication for joint pain. Besides OTC drugs, we also offer a wide range of products such as quasi drugs, food for specified health uses, health foods and cosmetics. |
| Leveraging the Results of Our M&A toward a New Stage as a Global Company |
|
|
|
In R&D, Zeria efficiently allocates resources directed toward independently developing novel compounds in our fields of specialization. Moreover, while promoting joint development with domestic and overseas companies and research institutions, we offer products with outstanding efficacy and safety that have earned the confidence of consumers and healthcare professionals.
Zeria will actively undertake overseas business development utilizing the results of M&A toward a new stage of growth as a global company.
Looking to the future, based on our corporate motto, “Making health is making happiness,” Zeria will continue helping people realize their desire to stay youthful and healthy, both physically and mentally, by aiming to “Excel in quality at every level” in our products and all corporate activities.
|
|